title: Why measure tumours?
abstract: This article questions the scientific justification of ingrained radiologic practices exemplified by size measurements of childhood solid tumours. This is approached by a critical review of staging systems from a selection of paediatric oncological treatment protocols. Local staging remains size-dependent for some tumour types. The consequent stage assignment can significantly influence treatment intensity. Still, the protocols tend not to give precise guidance on how to perform scans and standardise measurements. Also, they do not estimate or account for the inevitable variability in measurements. Counts and measurements of lung nodules are, within some tumour groups, used for diagnosis of metastatic disease. There is, however, no evidence that nodule size is a useful discriminator of benign and malignant lung nodules. The efficacy of imaging depends chiefly on observations being precise, accurate and valid for the desired diagnostic purpose. Because measurements without estimates of their errors are meaningless, studies of variability dependent on tumour shape and location, imaging device and observer need to be encouraged. Reproducible observations make good candidates for staging parameters if they have prognostic validity and at the same time show little covariation with (thereby adding new information to) the existing staging system. The lack of scientific rigour has made the validity of size measurement very difficult to assess. Action is needed, the most important being radiologists' active contribution in development of oncological staging systems, attention to standardisation, knowledge about errors in measurement and protection against undue influence of such errors in the staging of the individual child.
authors.affiliation: Radiology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK, oeolsen.pedrad@me.com.
authors.forename: Øystein E
authors.initials: ØE
authors.lastname: Olsen
mesh_terms: D003952:Diagnostic Imaging / Q000592:standards*; D005060:Europe; D006801:Humans; D007089:Image Enhancement / Q000592:standards*; D009367:Neoplasm Staging; D009369:Neoplasms / Q000473:pathology*; D017410:Practice Guidelines as Topic; D011871:Radiology / Q000592:standards*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D047368:Tumor Burden